Suppr超能文献

1971 - 2001年英格兰和威尔士原发性肝癌和胆管癌发病率趋势

Trends in the incidence of primary liver and biliary tract cancers in England and Wales 1971-2001.

作者信息

West J, Wood H, Logan R F A, Quinn M, Aithal G P

机构信息

Division of Epidemiology and Public Health, University of Nottingham Medical School, Queen's Medical Centre University Hospital, Nottingham NG7 2UH, UK.

出版信息

Br J Cancer. 2006 Jun 5;94(11):1751-8. doi: 10.1038/sj.bjc.6603127.

Abstract

In the last two decades, mortality from primary liver cancer has increased in the UK. We aimed to determine whether the incidence trends for these cancers were similar and in particular if the increasing occurrence of cholangiocarcinoma has continued. We calculated directly age-standardised incidence rates (using the European standard population) by subsite and histological type for all cancers of the liver, gallbladder and biliary tract in England and Wales from 1971 to 2001, using cancer registry data. The incidence of cancers of the liver, gallbladder and biliary tract increased, with the greatest rise, around 12-fold, in intrahepatic bile duct cancers. The rate of liver cell cancer increased by around 45% in males, but by <10% in females. There were marked reductions in the incidence of gallbladder and extrahepatic bile duct cancer. Cholangiocarcinoma increased around 16-fold and became the most common type of primary liver cancer in females, while hepatocellular carcinoma remained the commonest type in males. The age-specific incidence rates showed that intrahepatic bile duct cancer continued to increase throughout the 1990s in those aged 75 and over, while liver cell cancer decreased in the older age groups. In conclusion, there were increases in the incidence of primary liver cancer, which have been particularly dramatic for intrahepatic bile duct cancer, over the last three decades of the 20th century in England and Wales. There has been a halving in the incidence of gallbladder cancer and a reduction of a third in extrahepatic bile duct cancer.

摘要

在过去二十年中,英国原发性肝癌的死亡率有所上升。我们旨在确定这些癌症的发病率趋势是否相似,特别是胆管癌发病率的持续上升情况是否依然存在。我们利用癌症登记数据,计算了1971年至2001年英格兰和威尔士所有肝癌、胆囊癌和胆管癌按亚部位和组织学类型直接标准化的发病率(采用欧洲标准人口)。肝癌、胆囊癌和胆管癌的发病率均有所上升,其中肝内胆管癌上升幅度最大,约为12倍。男性肝细胞癌发病率上升约45%,而女性上升幅度小于10%。胆囊癌和肝外胆管癌的发病率显著下降。胆管癌发病率上升约16倍,成为女性最常见的原发性肝癌类型,而肝细胞癌仍是男性最常见的类型。年龄别发病率显示,在75岁及以上人群中,肝内胆管癌在整个20世纪90年代持续上升,而老年组的肝细胞癌发病率则有所下降。总之,在20世纪最后三十年里,英格兰和威尔士原发性肝癌的发病率有所上升,其中肝内胆管癌的上升尤为显著。胆囊癌发病率减半,肝外胆管癌发病率降低三分之一。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42df/2361300/2bfc0e011091/94-6603127f1.jpg

相似文献

1
Trends in the incidence of primary liver and biliary tract cancers in England and Wales 1971-2001.
Br J Cancer. 2006 Jun 5;94(11):1751-8. doi: 10.1038/sj.bjc.6603127.
2
Rising trends in cholangiocarcinoma: is the ICD classification system misleading us?
J Hepatol. 2012 Apr;56(4):848-54. doi: 10.1016/j.jhep.2011.11.015. Epub 2011 Dec 13.
3
Incidence and mortality of primary liver cancer in England and Wales: changing patterns and ethnic variations.
World J Gastroenterol. 2014 Feb 14;20(6):1544-53. doi: 10.3748/wjg.v20.i6.1544.
4
Biliary Tract and Primary Liver Tumors: Who, What, and Why?
Surg Oncol Clin N Am. 2019 Oct;28(4):519-538. doi: 10.1016/j.soc.2019.06.012.
5
Biliary tract cancer incidence and trends in the United States by demographic group, 1999-2013.
Cancer. 2019 May 1;125(9):1489-1498. doi: 10.1002/cncr.31942. Epub 2019 Jan 15.
7
Incidence and survival for hepatic, pancreatic and biliary cancers in England between 1998 and 2007.
Cancer Epidemiol. 2012 Aug;36(4):e207-14. doi: 10.1016/j.canep.2012.03.010. Epub 2012 Apr 23.
8
Biliary tract cancers in Cote-d'Or (France): incidence and natural history.
J Epidemiol Community Health. 1987 Dec;41(4):344-8. doi: 10.1136/jech.41.4.344.
9
Incidence and Mortality of Cancers of the Biliary Tract, Gallbladder, and Liver by Sex, Age, Race/Ethnicity, and Stage at Diagnosis: United States, 2013 to 2017.
Cancer Epidemiol Biomarkers Prev. 2021 Sep;30(9):1607-1614. doi: 10.1158/1055-9965.EPI-21-0265. Epub 2021 Jul 8.
10
Gallbladder and extrahepatic bile duct cancers in the Americas: Incidence and mortality patterns and trends.
Int J Cancer. 2020 Aug 15;147(4):978-989. doi: 10.1002/ijc.32863. Epub 2020 Jan 21.

引用本文的文献

1
Cholangiocarcinoma in Denmark: Time-trends in incidence and mortality.
JHEP Rep. 2025 Jun 24;7(9):101493. doi: 10.1016/j.jhepr.2025.101493. eCollection 2025 Sep.
3
Survival disparities among racial groups with hepatic malignant tumors.
World J Gastrointest Oncol. 2024 Jul 15;16(7):2999-3010. doi: 10.4251/wjgo.v16.i7.2999.
4
The Recent Trends of Systemic Treatments and Locoregional Therapies for Cholangiocarcinoma.
Pharmaceuticals (Basel). 2024 Jul 8;17(7):910. doi: 10.3390/ph17070910.
6
Recent Advances in Systemic Therapy for Advanced Intrahepatic Cholangiocarcinoma.
Liver Cancer. 2023 Jun 8;13(2):119-135. doi: 10.1159/000531458. eCollection 2024 Apr.
9
Regional variation in routes to diagnosis of cholangiocarcinoma in England from 2006 to 2017.
World J Gastroenterol. 2023 Jun 28;29(24):3825-3842. doi: 10.3748/wjg.v29.i24.3825.
10
Paradigm shift of chemotherapy and systemic treatment for biliary tract cancer.
World J Gastrointest Oncol. 2023 Jun 15;15(6):959-972. doi: 10.4251/wjgo.v15.i6.959.

本文引用的文献

1
Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study.
Gastroenterology. 2005 Mar;128(3):620-6. doi: 10.1053/j.gastro.2004.12.048.
4
Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase?
J Hepatol. 2004 Mar;40(3):472-7. doi: 10.1016/j.jhep.2003.11.030.
7
Rising incidence of hepatocellular carcinoma in the United States.
N Engl J Med. 1999 Mar 11;340(10):745-50. doi: 10.1056/NEJM199903113401001.
8
Increase in primary liver cancer in the UK, 1979-94.
Lancet. 1997 Oct 18;350(9085):1142-3. doi: 10.1016/S0140-6736(05)63789-0.
10
ERCP--the first twenty years.
Gastrointest Endosc. 1988 May-Jun;34(3):277-8. doi: 10.1016/s0016-5107(88)71331-0.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验